The Cure Parkinson’s Trust is a private-limited-guarant-nsc-limited-exemption organization established in 2005, dedicated to the pursuit of a cure for Parkinson’s disease. Based at 120 New Cavendish Street, London, W1W 6XX, the Trust operates with a primary focus on funding, facilitating, and encouraging research initiatives aimed at developing effective treatments and ultimately, a cure for the condition. The Trust’s activities encompass a broad spectrum of scientific research, supporting studies across various disciplines including neuroscience, genetics, and pharmacology. We actively engage with academic institutions, research centers, and pharmaceutical companies to identify promising avenues for investigation. A core component of our strategy involves providing financial support, strategic partnerships, and access to resources crucial for advancing Parkinson’s research. The Trust’s international presence is currently limited, focusing exclusively on operations within the United Kingdom. We employ a team of skilled professionals with a strong understanding of scientific research and funding mechanisms. Our key focus remains on accelerating the discovery and development of therapies that address the underlying causes and symptoms of Parkinson’s disease. We are committed to contributing significantly to this vital global health challenge.

The Cure Parkinson’s Trust is a private-limited-guarant-nsc-limited-exemption organization established in 2005, dedicated to the pursuit of a cure for Parkinson’s disease. Based at 120 New Cavendish Street, London, W1W 6XX, the Trust operates with a primary focus on funding, facilitating, and encouraging research initiatives aimed at developing effective treatments and ultimately, a cure for the condition. The Trust’s activities encompass a broad spectrum of scientific research, supporting studies across various disciplines including neuroscience, genetics, and pharmacology. We actively engage with academic institutions, research centers, and pharmaceutical companies to identify promising avenues for investigation. A core component of our strategy involves providing financial support, strategic partnerships, and access to resources crucial for advancing Parkinson’s research. The Trust’s international presence is currently limited, focusing exclusively on operations within the United Kingdom. We employ a team of skilled professionals with a strong understanding of scientific research and funding mechanisms. Our key focus remains on accelerating the discovery and development of therapies that address the underlying causes and symptoms of Parkinson’s disease. We are committed to contributing significantly to this vital global health challenge.